biotech · Acute Myeloid Leukemia · Sarcoma,Soft Tissue · MBRX
Moleculin Biotech
Moleculin Biotech is a biotech organization headquartered in Houston, USA. It trades on NYSE under ticker MBRX. Primary therapeutic focus areas include Acute Myeloid Leukemia, Sarcoma,Soft Tissue, Leukemia, Myeloid, Acut
Houston, USA HQ
2006 Founded
22 Employees
Public company Type
MBRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Houston, USA
- Founded
- 2006
- Employees
- 22
- Programs
- 9
- Drugs
- 10
- Patents
- 1
MOL4239
Phase 2 · small molecule · Psoriasis
MOL4239 for Psoriasis is a Phase 2 program (small_molecule) at Moleculin Biotech with 1 ClinicalTrials.gov record(s).
Internal code M-02
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Moleculin Biotech
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Psoriasis
- Status
- completed
- Trials
- 1